logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Masato Nakamura

Aizawa Hospital
H指数:52
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MVI-targeted Carbon-ion Radiotherapy Combined with Immunotherapy for Advanced Hepatocellular Carcinoma: Phase Ib DEPARTURE Trial
JHEP Reports
IF7.5
2026-02-050
OAAI
Sadahisa Ogasawara; Keisuke Koroki; Hirokazu Makishima; Masaru Wakatsuki; Asahi Takahashi; Makoto Fujiya; Sae Yumita; Miyuki Nakagawa; Hiroaki Kanzaki; Kazufumi Kobayashi; Masanori Inoue; Masato Nakamura; Naoya Kanogawa; Takayuki Kondo; Shingo Nakamoto; Tomoya Kurokawa; Yoshihito Ozawa; Yosuke Inaba; Soumith Paritala; Jingxuan Chen
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes

阿特珠单抗联合贝伐珠单抗治疗晚期肝细胞癌的疗效与肿瘤浸润淋巴细胞的关系

JHEP Reports
IF7.5
2025-10-010
OAAI
Hiroaki Kanzaki; Takamasa Ishino; Sadahisa Ogasawara; Takahiro Tsuchiya; Makoto Fujiya; Midori Sawada; Ryo Izai; Teppei Akatsuka; Chihiro Miwa; Takuya Yonemoto; Sae Yumita; Miyuki Nakagawa; Ryuta Kojima; Keisuke Koroki; Masanori Inoue; Kazufumi Kobayashi; Naoya Kanogawa; Masato Nakamura; Takayuki Kondo; Shingo Nakamoto; Tsukasa Takayashiki; Yuka Takano; Kaho Takata; Jason Lin; Masahito Kawazu; Jun-ichiro Ikeda; Masayuki Ohtsuka; Yujin Hoshida; Mina Komuta; Yosuke Togashi
Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinoma

随机对照II期研究，比较regorafenib两种剂量在晚期肝细胞癌二线治疗中的应用。

JHEP Reports
IF7.5
2025-07-110
OAAI
Keisuke Koroki; Sadahisa Ogasawara; Sae Yumita; Miyuki Nakagawa; Hiroaki Kanzaki; Kazufumi Kobayashi; Masanori Inoue; Masato Nakamura; Naoya Kanogawa; Takayuki Kondo; Eiichiro Suzuki; Yoshihiko Ooka; Shingo Nakamoto; Yuki Shiko; Yoshihito Ozawa; Yosuke Inaba
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma
BIOCHEMICAL PHARMACOLOGY
IF5.6
2025-02-010
PRE
Qiang, Na; Ao, Junjie; Nakamura, Masato; Katayama, Keichi; Zhang, Jiaqi; Kogure, Tadayoshi; Ogawa, Keita; Kanzaki, Hiroaki; Kojima, Ryuta; Koroki, Keisuke; Kobayashi, Kazufumi; Inoue, Masanori; Kanogawa, Naoya; Kiyono, Soichiro; Nakagawa, Ryo; Kondo, Takayuki; Ogasawara, Sadahisa; Nakamoto, Shingo; Muroyama, Ryosuke; Kato, Jun; Kato, Naoya
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)
INVESTIGATIONAL NEW DRUGS
IF2.7
2024-06-060
OAAI
Kobayashi, Kazufumi; Ogasawara, Sadahisa; Itobayashi, Ei; Okubo, Tomomi; Itokawa, Norio; Nakamura, Kazuyoshi; Moriguchi, Michihisa; Watanabe, Shunji; Ikeda, Masafumi; Kuroda, Hidekatsu; Kawaoka, Tomokazu; Hiraoka, Atsushi; Yasui, Yutaka; Kuzuya, Teiji; Sato, Rui; Kanzaki, Hiroaki; Koroki, Keisuke; Inoue, Masanori; Nakamura, Masato; Kiyono, Soichiro; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Ozawa, Yoshihito; Tsuchiya, Kaoru; Atsukawa, Masanori; Aikata, Hiroshi; Aramaki, Takeshi; Oka, Shiro; Morimoto, Naoki; Kurosaki, Masayuki; Itoh, Yoshito; Izumi, Namiki; Kato, Naoya
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy
LIVER CANCER
IF9.1
2024-05-210
OAAI
Inoue, Masanori; Ogasawara, Sadahisa; Kobayashi, Kazufumi; Okubo, Tomomi; Itokawa, Norio; Obu, Masamichi; Fujimoto, Kentaro; Unozawa, Hidemi; Yumita, Sae; Fujiwara, Kisako; Nakagawa, Miyuki; Kanzaki, Hiroaki; Koroki, Keisuke; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Nagashima, Kengo; Itobayashi, Ei; Atsukawa, Masanori; Koma, Yoshihiro; Azemoto, Ryosaku; Kato, Naoya
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma
JOURNAL OF GASTROENTEROLOGY
IF5.5
2024-04-071
OAAI
Fujiwara, Kisako; Kondo, Takayuki; Fujimoto, Kentaro; Yumita, Sae; Ogawa, Keita; Ishino, Takamasa; Nakagawa, Miyuki; Iwanaga, Terunao; Tsuchiya, Satoshi; Koroki, Keisuke; Kanzaki, Hiroaki; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Ogasawara, Sadahisa; Nakamoto, Shingo; Chiba, Tetsuhiro; Koizumi, Jun; Kato, Jun; Kato, Naoya
Exploring the efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Kanzaki, Hiroaki; Ishino, Takamasa; Ogasawara, Sadahisa; Yumita, Sae; Nakagawa, Miyuki; Kojima, Ryuta; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Kanogawa, Naoya; Kiyono, Soichiro; Nakamura, Masato; Kondo, Takayuki; Nakamoto, Shingo; Takayashiki, Tsukasa; Lin, Jason; Kawazu, Masahito; Komuta, Mina; Ikeda, Jun-ichiro; Ohtsuka, Masayuki; Togashi, Yosuke; Kato, Naoya
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer

在TRUSTY研究中使用血浆血管生成相关因子和无细胞DNA进行探索性生物标志物分析: 一项关于三氟尿苷/替匹拉西加贝伐单抗作为转移性结直肠癌二线治疗的随机II/III期研究

TARGETED ONCOLOGY
IF4
2024-01-094
OAAI
Sunakawa, Yu; Kuboki, Yasutoshi; Watanabe, Jun; Terazawa, Tetsuji; Kawakami, Hisato; Yokota, Mitsuru; Nakamura, Masato; Kotaka, Masahito; Sugimoto, Naotoshi; Ojima, Hitoshi; Oki, Eiji; Kajiwara, Takeshi; Yamamoto, Yoshiyuki; Tsuji, Yasushi; Denda, Tadamichi; Tamura, Takao; Ishihara, Soichiro; Taniguchi, Hiroya; Nakajima, Takako Eguchi; Morita, Satoshi; Shirao, Kuniaki; Takenaka, Naruhito; Ozawa, Daisuke; Yoshino, Takayuki

研究方向

暂未获取到该数据
S
Shingo Nakamoto
H 指数:30论文数:231被引数:2,716
S
Sadahisa Ogasawara
H 指数:38论文数:339被引数:1.2万
H
Hiroaki Kanzaki
H 指数:19论文数:141被引数:1,032
N
Naoya Kato
H 指数:61论文数:622被引数:1.4万
K
Kazufumi Kobayashi
H 指数:20论文数:150被引数:1,197
S
Soichiro Kiyono
H 指数:19论文数:161被引数:1,108
T
Tetsuhiro Chiba
H 指数:47论文数:357被引数:7,326
T
Tatsuo Kanda
H 指数:53论文数:551被引数:1.1万
K
Keisuke Koroki
H 指数:14论文数:119被引数:606
N
Naoya Kanogawa
H 指数:21论文数:157被引数:1,485